Alkem Laboratories Limited Cash Flow Conversion Efficiency
Alkem Laboratories Limited cash flow conversion efficiency. Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.37 Billion ≈ $90.47 Million USD) by net assets (Rs138.11 Billion ≈ $1.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Alkem Laboratories Limited (2010–2025)
Cash flow conversion efficiency of Alkem Laboratories Limited from 2010 to 2025. This chart illustrates how Alkem Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Alkem Laboratories Limited (ALKEM) share price today for real-time trading data and today's change.
Alkem Laboratories Limited Cash Flow Conversion Ratio Explained
Alkem Laboratories Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Alkem Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alkem Laboratories Limited ranked by their cash flow conversion efficiency. Also see Alkem Laboratories Limited market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Artemis Gold Inc
V:ARTG
|
0.196x |
|
Yanzhou Coal Mining Company Limited
F:YZC
|
0.000x |
|
BlueFocus Communication Group
SHE:300058
|
0.064x |
|
Birkenstock Holding plc
NYSE:BIRK
|
0.008x |
|
ZEEKR Intelligent Technology Holding Limited
NYSE:ZK
|
0.026x |
|
Tripod Technology Corp
TW:3044
|
0.058x |
|
Adani Total Gas Limited
NSE:ATGL
|
0.017x |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
0.017x |
Annual Cash Flow Conversion Efficiency for Alkem Laboratories Limited (2010–2025)
The table below shows the annual cash flow conversion efficiency of Alkem Laboratories Limited from 2010 to 2025. Review Alkem Laboratories Limited (ALKEM) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs124.34 Billion ≈ $1.34 Billion |
Rs19.13 Billion ≈ $206.87 Million |
0.154x | -15.39% |
| 2024-03-31 | Rs107.14 Billion ≈ $1.16 Billion |
Rs19.48 Billion ≈ $210.68 Million |
0.182x | +1.96% |
| 2023-03-31 | Rs94.35 Billion ≈ $1.02 Billion |
Rs16.82 Billion ≈ $181.96 Million |
0.178x | +42.00% |
| 2022-03-31 | Rs88.47 Billion ≈ $956.81 Million |
Rs11.11 Billion ≈ $120.15 Million |
0.126x | -24.97% |
| 2021-03-31 | Rs75.58 Billion ≈ $817.37 Million |
Rs12.65 Billion ≈ $136.79 Million |
0.167x | +80.46% |
| 2020-03-31 | Rs63.09 Billion ≈ $682.29 Million |
Rs5.85 Billion ≈ $63.27 Million |
0.093x | -33.53% |
| 2019-03-31 | Rs55.72 Billion ≈ $602.59 Million |
Rs7.77 Billion ≈ $84.07 Million |
0.140x | +151.85% |
| 2018-03-31 | Rs49.85 Billion ≈ $539.14 Million |
Rs2.76 Billion ≈ $29.87 Million |
0.055x | -46.11% |
| 2017-03-31 | Rs45.83 Billion ≈ $495.62 Million |
Rs4.71 Billion ≈ $50.95 Million |
0.103x | -46.36% |
| 2016-03-31 | Rs37.87 Billion ≈ $409.55 Million |
Rs7.26 Billion ≈ $78.50 Million |
0.192x | +81.66% |
| 2015-03-31 | Rs30.85 Billion ≈ $333.60 Million |
Rs3.25 Billion ≈ $35.20 Million |
0.106x | -3.41% |
| 2014-03-31 | Rs26.55 Billion ≈ $287.14 Million |
Rs2.90 Billion ≈ $31.37 Million |
0.109x | +65.86% |
| 2013-03-31 | Rs23.74 Billion ≈ $256.72 Million |
Rs1.56 Billion ≈ $16.91 Million |
0.066x | +5.93% |
| 2012-03-31 | Rs19.06 Billion ≈ $206.08 Million |
Rs1.18 Billion ≈ $12.81 Million |
0.062x | -91.34% |
| 2011-03-31 | Rs11.67 Billion ≈ $126.25 Million |
Rs8.38 Billion ≈ $90.62 Million |
0.718x | +1128.81% |
| 2010-03-31 | Rs12.05 Billion ≈ $130.35 Million |
Rs-840.93 Million ≈ $-9.09 Million |
-0.070x | -- |
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective… Read more